SIETES :: 92916 citas

Resultados de la búsqueda por DICLOFENACO REFINAR BÚSQUEDA

1.

Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]

2.

Zeng C, Dubreuil M, LaRochelle MR, Lu N, Wei J, Choi HK, Lei G, Zhang Y. Association of tramadol with all-cause mortality among patients with osteoarthritis. JAMA 2019;321:12 de marzo. [Ref.ID 103057]

3.

Brutcher RE, Kurihara C, Bicket MC, Moussavian-Yousef P, Reece DE, Solomon LM, Griffith SR, Jamison DE, Cohen SP. Compounded topical pain creams to treat localized chronic pain: a randomized controlled trial. Ann Intern Med 2019;170:mayo. [Ref.ID 103014]

4.

Dubreuil M, Louie-Gao Q, Peloquin CE, Choi HK, Zhang Y, Neogi T. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis. Ann Rheum Dis 2018;77:agosto. [Ref.ID 102825]

5.

Bally M, Beauchamp M-E, Abrahamowicz M, Nadeau L, Brophy JM. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure. Pharmacoepidemiol Drug Saf 2018;27:69-77. [Ref.ID 102531]

6.

Grosser T, Ricciotti E, Fitzgerald GA. The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci 2017;38:733-48. [Ref.ID 101990]

7.

da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 2017;390:8 de julio. [Ref.ID 101669]

8.

Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ 2017;357:j1909. [Ref.ID 101568]

9.

Sondergaard KB, Weeke P, Wissenberg M, Olsen A-MS, Fosbol EL, Lippert FK, Torp-Pedersen C, Gislason GH, Folke F. Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case–time–control study. Eur Heart J 2017;3:100-7. [Ref.ID 101478]

10.

Anónimo. AINS: infections des tissus mous et complications suppuratives de pneumopathies bactériennes. Prescrire 2017;37:109. [Ref.ID 101429]

11.

Anónimo. Encéphalopathies postérieures réversibles d'origine médicamenteuse. Prescrire 2016;36:907-10. [Ref.ID 101007]

12.

Patrono C. Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective. Br J Clin Pharmacol 2016;82:957-64. [Ref.ID 100827]

13.

Nadal M, Cols M. Hacia una mejor atención a los pacientes: medicamentos que hay que evitar y posibles alternativas.. Formación Médica Continuada en Atención Primaria 2016;23:231-44. [Ref.ID 100328]

14.

da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet 2016;387:2093-105. [Ref.ID 100313]

15.

Moore N, Salvo F, Duong M, Gulmez SE. Does paracetamol still have a future in osteoarthritis?. Lancet 2016;387:2065-6. [Ref.ID 100312]

16.

Pathan SA, Mitra B, Straney LD, Afzal MS, Anjum S, Shukla D, Morley K, Al Hilli SA, Al Rumaihi K, Thomas SH, Cameron PA. Delivering safe and effective analgesia for management of renal colic in the emergency department: a double-blind, multigroup, randomised controlled trial. Lancet 2016;387:1999-2007. [Ref.ID 100295]

17.

Knoedler JJ, Lieske JC. Non-steroidal anti-inflammatory drugs for renal colic. Lancet 2016;387:1971-2. [Ref.ID 100294]

18.

Derry S, Wiffen P, Moore A. Topical nonsteroidal anti-inflammatory drugs for acute musculoskeletal pain. JAMA 2016;315:813-4. [Ref.ID 100022]

19.

Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD. Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf 2016;25:628-36. [Ref.ID 100019]

20.

Anónimo. Riesgos de los AINE en pacientes que reciben tratamiento antitrombótico. Butlletí Groc 2015;28:5-10. [Ref.ID 99839]